Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Some Thai plants, especially Carthamus tinctorius, could help prevent hair loss and promote hair growth without adverse effects.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Genetics and hormones cause hair loss; finasteride treats it safely.

Microneedling can help stimulate hair growth, especially when used with other treatments, but it's not better than existing therapies.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Certain drugs that block specific enzymes can help treat prostate diseases.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Hair follicle regeneration possible, more research needed.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.